Logo image of LPTX

LEAP THERAPEUTICS INC (LPTX) Stock Fundamental Analysis

USA - NASDAQ:LPTX - US52187K2006 - Common Stock

0.4472 USD
-0.01 (-2.57%)
Last: 10/31/2025, 8:00:01 PM
0.4655 USD
+0.02 (+4.09%)
After Hours: 10/31/2025, 8:00:01 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LPTX. LPTX was compared to 534 industry peers in the Biotechnology industry. The financial health of LPTX is average, but there are quite some concerns on its profitability. LPTX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LPTX has reported negative net income.
In the past year LPTX has reported a negative cash flow from operations.
In the past 5 years LPTX always reported negative net income.
In the past 5 years LPTX always reported negative operating cash flow.
LPTX Yearly Net Income VS EBIT VS OCF VS FCFLPTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

LPTX has a Return On Assets of -327.74%. This is amonst the worse of the industry: LPTX underperforms 94.19% of its industry peers.
LPTX has a Return On Equity of -1148.94%. This is amonst the worse of the industry: LPTX underperforms 81.65% of its industry peers.
Industry RankSector Rank
ROA -327.74%
ROE -1148.94%
ROIC N/A
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
LPTX Yearly ROA, ROE, ROICLPTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LPTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LPTX Yearly Profit, Operating, Gross MarginsLPTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K -2.5K

More info and screens

5

2. Health

2.1 Basic Checks

LPTX has more shares outstanding than it did 1 year ago.
LPTX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for LPTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LPTX Yearly Shares OutstandingLPTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
LPTX Yearly Total Debt VS Total AssetsLPTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

LPTX has an Altman-Z score of -43.79. This is a bad value and indicates that LPTX is not financially healthy and even has some risk of bankruptcy.
LPTX has a worse Altman-Z score (-43.79) than 92.70% of its industry peers.
There is no outstanding debt for LPTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -43.79
ROIC/WACCN/A
WACCN/A
LPTX Yearly LT Debt VS Equity VS FCFLPTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 1.34 indicates that LPTX should not have too much problems paying its short term obligations.
LPTX has a worse Current ratio (1.34) than 83.15% of its industry peers.
A Quick Ratio of 1.34 indicates that LPTX should not have too much problems paying its short term obligations.
LPTX's Quick ratio of 1.34 is on the low side compared to the rest of the industry. LPTX is outperformed by 82.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
LPTX Yearly Current Assets VS Current LiabilitesLPTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.00% over the past year.
EPS 1Y (TTM)21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LPTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.37% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5Y13.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LPTX Yearly Revenue VS EstimatesLPTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2029 2030 2031 2032 50M 100M 150M
LPTX Yearly EPS VS EstimatesLPTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPTX. In the last year negative earnings were reported.
Also next year LPTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LPTX Price Earnings VS Forward Price EarningsLPTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LPTX Per share dataLPTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

LPTX's earnings are expected to grow with 19.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.62%
EPS Next 3Y19.23%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LPTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LEAP THERAPEUTICS INC

NASDAQ:LPTX (10/31/2025, 8:00:01 PM)

After market: 0.4655 +0.02 (+4.09%)

0.4472

-0.01 (-2.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners22.06%
Inst Owner Change-0.64%
Ins Owners0.46%
Ins Owner Change0%
Market Cap25.33M
Revenue(TTM)N/A
Net Income(TTM)-65685000
Analysts43.33
Price Target3.06 (584.26%)
Short Float %5.01%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.34%
Min EPS beat(2)-35.23%
Max EPS beat(2)4.54%
EPS beat(4)2
Avg EPS beat(4)-5.33%
Min EPS beat(4)-35.23%
Max EPS beat(4)10.13%
EPS beat(8)5
Avg EPS beat(8)0.77%
EPS beat(12)7
Avg EPS beat(12)-17.41%
EPS beat(16)9
Avg EPS beat(16)-16.37%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.43
P/tB 4.43
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS0
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -327.74%
ROE -1148.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z -43.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5Y13.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.77%
OCF growth 3YN/A
OCF growth 5YN/A

LEAP THERAPEUTICS INC / LPTX FAQ

What is the fundamental rating for LPTX stock?

ChartMill assigns a fundamental rating of 2 / 10 to LPTX.


What is the valuation status for LPTX stock?

ChartMill assigns a valuation rating of 0 / 10 to LEAP THERAPEUTICS INC (LPTX). This can be considered as Overvalued.


What is the profitability of LPTX stock?

LEAP THERAPEUTICS INC (LPTX) has a profitability rating of 0 / 10.


Can you provide the financial health for LPTX stock?

The financial health rating of LEAP THERAPEUTICS INC (LPTX) is 5 / 10.